Dr. Karen Reckamp, MD, MS, City of Hope Comprehensive Cancer Center in Duarte, California joined GRACE to discuss the role of immunotherapy for previously treated patients with non-small cell lung cancer.
Matthew J. LePley serves as the Treasurer of GRACE. A licensed CPA under the State of Washington, he has been practicing in the area of taxation and accounting since 2000. Currently he is a sole practitioner under Sixty-One Consulting, PLLC providing tax consulting and CFO services to high-net worth individuals, families, and start-up companies. Previous to Sixty-One Consulting, PLLC, Mr.
Buddy is a strategic thought leader in new media technologies with 16+ years of digital content strategy experience. He has written and spoken extensively about healthcare marketing, social networks, marketing storytelling, web technologies and multimedia. He is the author of five mass market books on content, creative techniques, and process. He launched and maintained award-winning health information websites and was one of the driving forces behind placing the first pharmaceutical brand on a social network.
Dr. Karen Reckamp, MD, MS, City of Hope Comprehensive Cancer Center in Duarte, California joined GRACE to discuss the role of angiogenesis in previously treated non-small cell lung cancer.
Matthew is a well-respected Associate Director, in Partnerships and Sponsorships, for the University of British Columbia.
He and his team are responsible for forming strategic alliances and corporate partnerships with a focus on event and property sponsorships and business deals. He routinely engages alumni and external parties, and has experience overseeing, on behalf of the university, a diverse array of sport tourism type events and successful business development initiatives.
David Gray has been involved in clinical drug development in the pharmaceutical and biotechnology industries for over twenty-five years including leadership positions in clinical operations and biostatistics. He feels fortunate to have participated in the development and approval of life-changing therapies including an aerosol antibiotic for cystic fibrosis and a targeted antibody drug conjugate for Hodgkin and T-cell lymphomas.
Nancy has a background in molecular biology and has over 20 years of experience in medical education and healthcare communications. Much of her professional experience has focused in the area of oncology, and has included oversight of grant funded educational programming, advisory board planning and execution, scientific communications and publication planning, clinical support and clinical trial awareness initiatives, as well as educational content development and dissemination.
Denise has over 30 years of varying experience in and out of the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency and effectiveness within the organization, as well as the daily processes and functions.
In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss PDL1 as a biomarker for second-line treatment.
Laya Dogmetchi is a 1993 graduate of the University of California at Irvine and earned her Juris Doctorate from Vermont Law School in 1996. She then attended the University of Washington School of Law, where she earned an LL.M. in “Marine Law and Affairs” in 1997. Laya has been practicing law in Southern California since 1997, and presently is a Principal/Partner at the law firm of Much Shelist, P.C. in Newport Beach, California.